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egulated fusion of mammalian lysosomes is critical to
their ability to acquire both internalized and biosyn-
thetic materials. Here, we report the identiﬁcation of
a novel human protein, hVam6p, that promotes lysosome
clustering and fusion in vivo. Although hVam6p exhibits
 
homology to the 
 
Saccharomyces cerevisiae
 
 vacuolar pro-
tein sorting gene product Vam6p/Vps39p, the presence of a
 
citron homology (CNH)
 
 
 
domain at the NH
 
2
 
 terminus is
unique to the human protein. Overexpression of hVam6p
results in massive clustering and fusion of lysosomes and
 
late endosomes into large (2–3 
 
 
 
m) juxtanuclear structures.
This effect is reminiscent of that caused by expression of a
R
 
constitutively activated Rab7. However, hVam6p exerts its
effect even in the presence of a dominant-negative Rab7,
suggesting that it functions either downstream of, or in par-
allel to, Rab7. Data from gradient fractionation, two-hybrid,
and coimmunoprecipitation analyses suggest that hVam6p
is a homooligomer, and that its self-assembly is mediated
by a clathrin heavy chain repeat domain in the middle of
the protein. Both the CNH and clathrin heavy chain repeat
domains are required for induction of lysosome clustering
and fusion. This study implicates hVam6p as a mammalian
tethering/docking factor characterized with intrinsic ability
to promote lysosome fusion in vivo.
 
Introduction
 
Membrane-bound organelles of the endocytic and secretory
pathways are continuously undergoing regulated fusion and
fission events that allow exchange of materials between
them. Before fusion, the organelles are brought in close
proximity by various tethering and docking factors (for re-
view see Waters and Pfeffer, 1999). This proximity enables
the action of a fusion machinery composed of NSF, SNAPs,
SNAREs, and other associated proteins (Sollner and Roth-
man, 1996). Members of the Rab family of small GTP-
binding proteins play roles in the recruitment of tethering/
docking factors and/or their coupling to the fusion machin-
ery (Novick and Zerial, 1997). The specificity of fusion
arises from the particular combination of tethering/docking
factors, SNAREs, and Rabs that can be assembled at sites of
fusion. Tethering/docking factors involved in different
transport steps tend to be step specific and often bear little
structural resemblance to one another. SNAREs and Rabs
involved in those steps, on the other hand, are structurally
related (Waters and Pfeffer, 1999). This suggests that once
specific tethering/docking has occurred, fusion ensues by a
conserved mechanism.
Fusion of mammalian lysosomes with other membrane-
bound organelles is key to their ability to acquire both inter-
nalized and biosynthetic materials (Kornfeld and Mellman,
1989; Luzio et al., 2000). Lysosomes have been shown to
fuse with late endosomes (Mullock et al., 1998; Pryor et al.,
2000; Ward et al., 2000) and phagosomes (Zimmerli et al.,
1996; Funato et al., 1997) (heterotypic fusion), as well as
with themselves (Bakker et al., 1997; Ward et al., 1997,
2000) (homotypic fusion). Late endosome–lysosome fusion,
in particular, has been the subject of much interest in recent
years. Late endosomes have been proposed to establish tran-
sient contacts with lysosomes (i.e., kiss-and-run; Storrie and
Desjardins, 1996) or to undergo complete fusion into a hy-
brid organelle from which lysosomes are later recovered by a
fission event (i.e., fusion–fission; Mullock et al., 1998; Pryor
et al., 2000). Although the occurrence of lysosome fusion
has been extensively documented, the identification of fac-
tors involved in this process, particularly in the specific teth-
ering and/or docking events, is still in its infancy. In vitro
studies of late endosome–lysosome fusion have revealed a re-
quirement for ATP, NSF, SNAPs, Rabs, as well as the
SNARE syntaxin 7 (Mullock et al., 1998, 2000; Pryor et al.,
2000; Ward et al., 2000), whereas in vivo overexpression
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studies have suggested a role for Rab7 (Bucci et al., 2000).
To date, no tethering/docking factors have been identified
that play a role in mammalian lysosome fusion.
Potential candidates for lysosomal tethering/docking factors
are mammalian homologues of 
 
Saccharomyces cerevisiae
 
 gene
products involved in vacuole fusion (for review see Wickner
and Haas, 2000). Among these are Vps11p, Vps18p, Vps16p,
Vps33p, Vam2p/Vps41p, and Vam6p/Vps39p, which assem-
ble on the vacuolar membrane into a complex referred to as
homotypic fusion and vacuole protein sorting (HOPS)*
(Eitzen et al., 2000; Seals et al., 2000; Ungermann et al.,
2000) or C-Vps complex (Sato et al., 2000; Wurmser et al.,
2000). This complex has been shown to cooperate with the
yeast homologue of mammalian Rab7, Ypt7p, to enable vacu-
ole fusion mediated by the SNAREs (Ungermann et al.,
1999, 2000; Eitzen et al., 2000; Sato et al., 2000; Seals et al.,
2000; Wurmser et al., 2000). In this study, we report the
identification and characterization of a human homologue of
 
S
 
.
 
 cerevisiae
 
 Vam6p/Vps39p (Nakamura et al., 1997), which
we refer to as hVam6p. We show that overexpression of this
protein in human cells induces massive clustering and fusion
of lysosomes, whereas early endosomes and other organelles of
the endocytic and secretory pathways remain unaffected.
hVam6p exerts these effects by associating with the cytoplas-
mic face of the lysosomal membrane. An NH
 
2
 
-terminal citron
homology (CNH) domain and a central clathrin homol-
ogy (CLH) repeat domain in hVam6p are required for lyso-
some clustering and fusion. These observations suggest that
hVam6p may function as a tethering/docking factor specifi-
cally involved in lysosome fusion.
 
Results
 
Identification and domain organization of human Vam6p
 
A novel human cDNA encoding a protein homologous to
the 
 
S
 
.
 
 cerevisiae
 
 vacuolar protein sorting gene product
Vam6p/Vps39p (Nakamura et al., 1997) was identified
through searches of DNA databases and 5
 
 
 
 RACE-PCR (Fig.
1 A). This cDNA encodes a protein designated hVam6p of
886 amino acid residues and a predicted molecular mass of
 
 
 
100 kD. hVam6p bears 26% identity and 42% overall
amino acid sequence homology to the COOH-terminal re-
gion of 
 
S
 
.
 
 cerevisiae
 
 Vam6p (Fig. 1, A and B). Homologues
of hVam6p were also identified in 
 
Drosophila melanogaster
 
(35% identity, 53% homology), 
 
Caenorhabditis elegans
 
 (30%
identity, 50% homology) (Fig. 1, A and B), and 
 
Schizosac-
charomyces pombe
 
 (24% identity, 41% homology) (Fig. 1 B).
Our searches also identified a second human homologue of
 
S
 
.
 
 cerevisiae
 
 Vam6p that had already been characterized as
the TGF-
 
 
 
 receptor-I–associated protein-1 (TRAP-1) (21%
identity, 40% homology) (Charng et al., 1998) (Fig. 1 B).
Theoretical analyses predict the presence of a CNH do-
main (Madaule et al., 1995) near the NH
 
2
 
 terminus of
hVam6p, TRAP-1, and their 
 
S
 
.
 
 pombe
 
, 
 
D
 
.
 
 melanogaster
 
,
 
 
 
and
 
C
 
.
 
 elegans
 
 homologues (Fig. 1, A and B). Although these
proteins exhibit significant homology to hVam6p through-
out the entire protein (Fig. 1 B, gray shaded blocks), the 
 
S
 
.
 
cerevisiae
 
 Vam6p lacks a defined CNH domain, and the re-
gion of significant homology commences only after the first
450 residues. CNH domains also exist near the COOH ter-
minus of several kinases involved in the jun kinase (JNK) ac-
tivation pathway (e.g., NIK and TNIK) and of the 
 
S
 
.
 
 cerevi-
siae
 
 Rho guanine nucleotide exchange factor Rom1p (Fig. 1
B). Little is known about the function of this domain, al-
though it has been proposed to regulate kinase activity (Fu
et al., 1999; Dan et al., 2000) and to mediate binding to the
GTP-bound forms of Rac and Rho (Madaule et al., 1995).
hVam6p and its homologues also contain a CLH motif
(Fig. 1, A and B) similar to seven such motifs present in the
leg domain of the clathrin heavy chain (Ybe et al., 1999).
Similar motifs are also found in the 
 
S
 
.
 
 cerevisiae
 
 vacuolar sort-
ing proteins Vam2p/Vps41p (Fig. 1 B), Vps18p, Vps11, and
Vps8p. These motifs have been proposed to mediate protein–
protein interactions leading to homo- or heterooligomeriza-
tion of the proteins (Ybe et al., 1999; Darsow et al., 2001).
Northern blot analysis demonstrated that hVam6p mRNA
is expressed in all human tissues examined (Fig. 1 C), indi-
cating that the protein may be widely expressed.
 
Coalescence of lysosomes and late endosomes 
caused by overexpression of hVam6p
 
S
 
.
 
 cerevisiae
 
 Vam6p has been implicated in tethering and/or
docking events that precede homotypic vacuole fusion
(Eitzen et al., 2000; Price et al., 2000a,b; Seals et al., 2000;
Wurmser et al., 2000). To assess whether hVam6p could
play a similar role in lysosome tethering/docking, we exam-
ined the effects of overexpressing Myc epitope–tagged
hVam6p (Myc–hVam6p) by transient transfection into
HeLa cells. Fixed-permeabilized cells were analyzed by indi-
rect immunofluorescence microscopy after double labeling
with antibodies to the Myc epitope and to the lysosomal inte-
gral membrane proteins, lamp-1 (Fig. 2, A–C), lamp-2 (Fig.
2, D–F), and CD63 (Fig. 2, G–I). Untransfected cells exhib-
ited the characteristic distribution of lysosomes, which were
more concentrated in the juxtanuclear area of the cytoplasm
but also extended toward the cell periphery (Fig. 2, A–I). In
contrast, cells overexpressing hVam6p displayed a striking
coalescence of lysosomes into a few large juxtanuclear struc-
tures (Fig. 2, A–I, arrows) with concomitant loss of periph-
eral lysosomes. These large structures were observed in virtu-
ally all hVam6p-overexpressing cells and contained all three
lysosomal membrane proteins tested, as well as the lysosomal
luminal hydrolase, cathepsin D (Fig. 2, J–L, arrows). The
distributions of the early endosomal marker, transferrin re-
ceptor, in cells overexpressing hVam6p (Fig. 2, M–O, arrow-
head), as well as various other endosomal, TGN, and Golgi
markers (i.e., EEA1, AP-1, and the 58-kD Golgi protein;
data not shown), were not affected. These observations sug-
gested that the morphological alterations induced by overex-
pression of hVam6p were specific to organelles containing ly-
sosomal membrane and luminal proteins.
The exogenously expressed hVam6p appeared to be
mostly cytosolic (Fig. 2, B, E, H, K, and N). To determine
whether the cytosolic pool could have masked a population
 
*Abbreviations used in this paper: CI-MPR, cation-independent man-
nose-6-phosphate receptor; CLH, clathrin homology; CNH, citron ho-
mology; GAL4ad, GAL4 transcription activation domain; GAL4bd,
GAL4 DNA–binding domain; GFP, green fluorescent protein; HOPS,
homotypic fusion and vacuole protein sorting; TRAP-1, TGF-
 
 
 
 recep-
tor-I–associated protein-1. 
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Figure 1. Sequence homology, domain organization, and expres-
sion of hVam6p. (A) Full-length amino acid sequences of human 
(Homo sapiens; Hs) Vam6p (hVam6p), a D. melanogaster (Dm) ho-
mologue, and a C. elegans (Ce) homologue were aligned together 
with residues 451–1049 of S. cerevisiae (Sc) Vam6p/Vps39p, using 
the ClustalW Multiple Sequences Alignment software (available at 
the European Bioinformatics Institute website http://www2.ebi.ac.uk/
clustalw/) and shaded using the BOXSHADE program. Identical and 
similar residues are indicated by black and gray shading, respec-
tively. The blue line denotes the hypothetical hVam6p CNH domain, 
which is conserved in Dm and Ce but not Sc. The brown line indi-
cates the position of the hypothetical hVam6p CLH domain, which is 
conserved in all four orthologues. Domains were identified by Pfam 
HMM database searches (available from Washington University at 
http://pfam.wustl.edu/hmmsearch.shtml) (B) Domain organization of 
Vam6p/Vps39p family members. Specific domains are color-coded 
and regions of significant homology to hVam6p are shown in blue 
(CNH), brown (CLH), and green. GenBank/EMBL/DDBJ accession 
numbers are as follows: Hs Vam6p/Vps39p (AF280814), Ds Vam6p 
(AAF55525), Ce Vam6p (T24712), Sp Vam6p (T38314), Hs TRAP-1 
(XP 002298), Sc Vam6p/Vps39p (BAA11758), Sc Rom1p (S64365), 
Hs Traf2 and NCK-interacting kinase (TNIK) (AF172270), Hs NCK-
interacting kinase–like (AAC83079), Hs Vam2p/Vps41p (P49754), Sc 
Vam2p/Vps41p (BAA19071). Note that whereas the S. cerevisiae 
CLH domain has previously been situated between residues 716 and 
900 (Wurmser et al., 2000); our domain analysis, using the Pfam pro-
gram, positions it between residues 512 and 676. DEP is a domain 
found in Dishevelled, Egl-10, and Pleckstrin. (C) Analysis of hVam6 
mRNA expression in different human tissues. Northern blots with 
mRNA from various human tissues were analyzed with a 
32P-labeled 
probe specific for the complete hVam6 mRNA. The positions of RNA 
size markers are indicated. 
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of membrane-associated hVam6p, we performed immunof-
luorescence microscopy of hVam6p-expressing HeLa cells
after extraction of the cytosol with 0.05% wt/vol saponin
before fixation. This procedure uncovered the presence of
hVam6p on the same large lysosomal structures that con-
tained lamp-1 (Fig. 2, P–R).
The localization of hVam6p in transfected HeLa cells was
further examined by immunoelectron microscopy of ul-
trathin frozen sections (Fig. 3). hVam6p was found to be as-
sociated with an electron dense halo surrounding 0.2–0.6
 
 
 
m vesicles that were part of large clusters (Fig. 3 A, 10-nm
gold particles, arrows). All of these vesicles were also labeled
 
for the lysosomal membrane protein, lamp-2 (Fig. 3 A, 15-
nm gold particles, arrowheads). Although many hVam6p-
coated vesicles did not contain cation-independent mannose
6-phosphate receptor (CI-MPR) (Fig 3 B, *), others con-
tained both hVam6p (Fig. 3 B, 10-nm gold particles, arrows)
and CI-MPR (Fig. 3 B, 15-nm gold particles, arrowhead),
and some had the appearance of multivesicular bodies. To-
gether, these observations suggest that hVam6p associates
with and induces clustering of lysosomes and late endosomes.
 
Functional assessment of hVam6p-induced 
lysosomal structures
 
The hVam6p-induced lysosomal structures could be labeled
with the acidotropic fluorescent probe, LysoTracker red, in-
dicating that they were acidic (Fig. 4, A–C, arrow). To de-
termine if they were also accessible to fluid-phase markers,
HeLa cells expressing Myc–hVam6p were allowed to inter-
nalize the fluid phase marker rhodamine–dextran for various
time periods. Cells were then fixed permeabilized cells
and subjected to indirect immunofluorescence to detect
hVam6p-expressing cells. At time points ranging from 15
min (not shown) to 1 h (Fig. 4, D–F), rhodamine–dextran
was found to be internalized equally well into typical ly-
sosomes in untransfected cells and lysosomal clusters in
hVam6p-transfected cells (Fig. 4 D, arrows), suggesting no
major change in accessibility to fluid phase markers upon ex-
pression of hVam6p.
To determine whether hVam6p-induced structures were
also capable of degrading protein cargo, we cotransfected
cells with a Tac fusion protein containing a dileucine-based
endocytic and lysosomal targeting signal, Tac-DKQTLL,
(Letourneur and Klausner, 1992), together with either
hVam6p or nonmyristylated Arf6 as a control. Pulse–chase
analysis of Tac-DKQTLL subsequent to both metabolic and
cell surface labeling demonstrated that cells transfected with
hVam6p were capable of degrading proteins with kinetics
similar to normal cells (Fig. 4 G). All of these observations
suggested that hVam6p-induced lysosomal structures, de-
spite their altered morphology, were still capable of receiving
and degrading materials delivered from the endocytic system.
 
Ultrastructural analysis of hVam6p-induced lysosomal 
structures loaded with internalized HRP
 
We took advantage of the ability to load the hVam6p-induced
lysosomal structures with fluid phase endocytic markers to an-
alyze their ultrastructure in more detail. Untransfected or
hVam6p-transfected HeLa cells were allowed to internalize
HRP for 4 h. After
 
 
 
standard
 
 
 
fixation, diaminobenzidine devel-
opment for HRP visualization, and resin
 
 
 
embedding, cell sec-
tions were analyzed by electron microscopy.
 
 
 
As expected,
untransfected cells displayed an array of 0.2–0.6-
 
 
 
m HRP-
positive vesicles scattered throughout the cytoplasm, most of
which likely corresponded to late endosomes and lysosomes
because of the long period of internalization (Fig. 5 A).
hVam6p-transfected HeLa cells, on the other hand, contained
at least three types of abnormal structures. The first type con-
sisted of large clusters of HRP-positive 0.2–0.6 
 
 
 
M vesicles,
most of which contained intraluminal vesicles or other mem-
branous inclusions (Fig. 5, B and C), similar to those seen on
Figure 2. Overexpression of hVam6p induces coalescence of lyso-
somal vesicles. (A–O) HeLa cells were transiently transfected with a 
plasmid encoding Myc–hVam6p. Cells were fixed, permeabilized, 
and incubated with rabbit polyclonal antibodies to the Myc epitope 
together with mouse monoclonal antibodies to lamp-1 (A–C), lamp-2 
(D–F), CD63 (G–I), or transferrin receptor (M–O), or rabbit polyclonal 
antibody to cathepsin D (J–L). Arrows (A, D, G, and J) indicate the coa-
lescence of lysosomes into large juxtanuclear structures. Arrowhead 
(M) indicates a transfected cell. (P–R) HA–hVam6p-transfected HeLa 
cells were extracted for 1 min with 0.05% (wt/vol) saponin before fixa-
tion. Cells were then fixed and incubated with rabbit polyclonal anti-
bodies to the HA epitope, together with mouse monoclonal antibodies 
to lamp-1. Bound antibodies were revealed by Cy3-conjugated don-
key anti–rabbit IgG (red channel) and Alexa-488–conjugated donkey 
anti–mouse antibody (green channel). Bar, 10  m. 
Lysosome tethering and fusion |
 
 Caplan et al. 113
 
ultrathin cryosections (Fig. 3). The second type of abnormal
structures were large (2–3 
 
 
 
m) vacuoles (Fig. 5, B and D).
Some of these vacuoles seemed empty, displaying the ap-
pearance of swollen vacuoles. Others had variable amounts
of HRP-positive materials, including 0.2–0.6 
 
 
 
M vesicles,
within their interior (Fig. 5 D). The third type was a combina-
tion of the former two in that clusters of 0.2–0.6-
 
 
 
M HRP-
positive vesicles were docked onto the membranes of the large
vacuoles (Fig. 5, B and E). Serial sectioning (not shown) re-
vealed that these three types of structures were situated next to
the nucleus, often nestled between nuclear lobes. These analy-
ses suggested a possible series of events induced by hVam6p, in
which late endosomes and lysosomes first cluster together and
then undergo fusion to generate large vacuoles.
 
Dynamics of lysosome clustering 
and fusion induced by hVam6p
 
To investigate the processes that led to the formation of ly-
sosomal clusters and large vacuoles over time, we monitored
the movement of lysosomes in live cells by time-lapse fluo-
rescence microscopy. To this aim, COS-7 and HeLa cells
were transfected with plasmids encoding green fluorescent
protein (GFP)–lamp-1 alone or GFP–lamp-1 and hVam6p.
In cells transfected with GFP–lamp-1 alone, lysosomes and/
or late endosomes exhibited bidirectional movement be-
tween the juxtanuclear area and sites in the cell periphery
(data not shown). In the doubly transfected cells, the effects
of hVam6p on lysosomes were concurrent with the expres-
sion of GFP–lamp-1, which made it necessary to image cells
already displaying incipient lysosome clustering. At early
time points, we could observe peripheral lysosomes moving
centripetally toward the center of the cell and attaching to or
merging with other lysosomes (Fig. 6 A, arrow, Video 1).
More centrally located lysosomes were also observed to clus-
ter and/or fuse with one another (Fig. 6 A, arrowhead, and
B; Videos 1 and 2). Over time, these clustering and fusion
events lead to the accumulation of large lysosomal structures
in the juxtanuclear area (Fig. 6 C; Video 3). These observa-
tions suggested that hVam6p causes lysosomes and late en-
dosomes to stick together in tight clusters and fuse, thus pre-
venting them from migrating back to the cell periphery.
(Videos 1, 2, and 3 are available at http://www.jcb.org/cgi/
content/full/200102142/DC1.)
Treatment of HeLa cells with 0.5 
 
 
 
M nocodazole immedi-
ately after transfection with an hVam6p-encoding plasmid did
not impede the coalescence of lamp-1–containing structures
in the cell periphery but did prevent their translocation to the
juxtanuclear area of the cell (Fig. 6 D). This indicated that mi-
crotubules are not involved in the clustering process itself but
in the localization of the clusters to the juxtanuclear area.
 
Functional relationship of hVam6p to Rab7
 
The effects of hVam6p on lysosomes are reminiscent of
those elicited by a constitutively active Rab7 Q67L mutant
(Bucci et al., 2000). To determine whether Rab7 nucleotide
cycling is necessary for the formation of hVam6p-induced
lysosome clusters, we transfected cells with wild-type GFP–
Rab7, constitutively activated GFP–Rab7 Q67L, or domi-
nant-negative GFP–Rab7 T22N, each alone or together
with hVam6p. Overexpression of wild type GFP–Rab7 did
not affect the distribution of endogenous lamp-1 (Fig. 7, A
and B) as previously reported (Bucci et al., 2000). However,
in cells transfected with GFP–Rab7 and hVam6p, both
GFP–Rab7 and lamp-1 were found in large juxtanuclear
clusters (Fig. 7, C and D, arrowheads). Since GFP–Rab7
Q67L induces an effect on lysosomes (Bucci et al., 2000)
that resembles that of hVam6p, we were unable to discern
any additional effect in cells expressing both of these pro-
teins (data not shown). However, GFP–Rab7 T22N, which
by itself causes dispersal of lysosomes from the juxtanuclear
region to the periphery (Bucci et al., 2000; and Fig. 7, E and
F, small arrows) did not block the coalescence of lysosomes
induced by hVam6p (Fig. 7, G and H, large arrow). These
findings imply that hVam6p exerts its affects either down-
stream of or in parallel to Rab7.
Figure 3. Association of hVam6p with clusters of lysosomes and 
late endosomes. HeLa cells were transiently transfected with HA–
hVam6p and processed for immunoelectron microscopy. Ultra-thin 
frozen sections were labeled with antibodies to HA (to detect 
hVam6p) and either endogenous lamp-2 (A) or endogenous CI-MPR 
(B). Bound antibodies were detected using conjugated protein 
A–gold. Arrows indicate the localization of hVam6p to a halo around 
the membranes of lysosomes and late endosomes (A and B, 10-nm 
gold particles), whereas arrowheads indicate the localization of 
lamp-2 (A, 15-nm gold particles) or CI-MPR (B, 15-nm gold parti-
cles), and the asterisk marks a structure labeled only for hVam6p. G, 
Golgi. Bars, 0.2  m. 
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Figure 4. Functional characterization of 
hVam6p-induced lysosomal clusters. (A–F) Live 
HeLa cells transiently transfected with Myc–
hVam6p were incubated with LysoTracker red 
(A–C) or rhodamine–dextran (D–F) for 1 h, and 
then fixed-permeabilized. Cells were incubated 
with a mouse monoclonal antibody to Myc, fol-
lowed by Alexa-488–conjugated donkey anti-
body to mouse IgG (B and E, green channel). 
The LysoTracker red and rhodamine–dextran 
are visible in the red channel (A and D). Arrows 
denote the accumulation of acidotropic (A) and 
fluid phase (D) markers within clustered lyso-
somes in hVam6p-transfected cells. Bar, 10  m. 
(G) HeLa cells were cotransfected with either 
Tac-DKQTLL and Myc–hVam6p, or Tac-
DKQTLL and a nonmyristylated Arf6 control. 
After 24 h, cotransfection efficiency was moni-
tored by indirect immunofluorescence (as de-
scribed in the legend to Fig. 2), and cells were 
pulsed for 30 min either by metabolic labeling 
(top) or cell surface biotinylation (bottom). The 
cells were then chased for the time points indi-
cated, harvested, lysed, subjected to immuno-
precipitation analysis using antibodies directed 
against Tac, and resolved on 4–20% SDS-
PAGE. Samples from metabolically labeled and 
biotinylated cells were visualized by autora-
diography and blotting with streptavidin–HRP, 
respectively.
Figure 5. Ultrastructural analysis of 
hVam6p-induced lysosomal structures la-
beled with internalized HRP. Untrans-
fected (A) or hVam6p-transfected (B–E) 
HeLa cells were subjected to a continuous 
4 h fluid phase uptake of HRP 24 h after 
transfection. (A) In control cells, HRP-con-
taining lysosomes and endosomes were 
small (0.2–0.6  m) and distributed 
throughout cell. (B) In hVam6p-trans-
fected cells, clusters of multivesicular 
HRP-positive vesicles (enlarged in C) 
and large (2–3  m) vacuoles situated 
next to the nucleus were visible. Some 
of these large vacuoles contained HRP 
(enlarged in D), whereas others ap-
peared to have smaller HRP-positive 
vesicles docking onto their membrane 
(enlarged in E). N, Nucleus. Bars: (A and 
B) 2  m; (C–E) 0.4  m. 
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Homooligomerization of hVam6p
 
A novel Rab7 effector termed RILP (Cantalupo et al., 2001)
has recently been identified through its binding to the consti-
tutively active Rab7 Q67L and has been demonstrated to me-
diate the effects of Rab7 on lysosome biogenesis. To determine
whether hVam6p interacts with either Rab7 Q67L or RILP,
we used a yeast two-hybrid approach. As expected, Rab7
Q67L and RILP interacted with one another (Cantalupo et al.,
2001; and Fig. 8 A). However, neither Rab7 Q67L nor RILP
displayed an interaction with hVam6p, consistent with the
idea that hVam6p acts independently of Rab7. A strong inter-
action was observed upon coexpression of GAL4 transcription
activation domain (GAL4ad)–hVam6p and GAL4 DNA–
binding domain (GAL4bd)–hVam6p (Fig. 8 A), however, sug-
gesting that hVam6p may be able to self-assemble.
To determine the size of potential hVam6p oligomers in
vivo, HA–hVam6p-transfected HeLa cells were labeled for
 
8 h with [
 
35
 
S]methionine, extracted with detergent, fraction-
ated by ultracentrifugation on a 5–20% sucrose gradient, and
analyzed by immunoprecipitation with anti-HA antibodies
(Fig. 8 B). A major species of 
 
 
 
105 kD was detected on
SDS-PAGE of anti-HA immunoprecipitates, in good agree-
ment with the predicted molecular mass of hVam6p (
 
 
 
100
kD). HA–hVam6p peaked in gradient fractions correspond-
ing to a molecular mass of 
 
 
 
317 kD, higher than the molec-
ular mass of the adaptor protein complex AP-2 (
 
 
 
270 kD).
This indicated that hVam6p is a component of an oligomeric
complex. Since no other major bands were detected in the
immunoprecipitates (Fig. 8 B), these results suggest that
hVam6p is a homooligomer, most likely a homotrimer.
To further assess the self-association of hVam6p in vivo,
HeLa cells were cotransfected with Myc–hVam6p and HA–
hVam6p (Fig. 9 B). After metabolic labeling, the cells were
lysed and subjected to immunoprecipitation–recapture anal-
Figure 6. Dynamics of hVam6p-induced lysosome clustering and fusion. COS-7 (A and C) or HeLa (B) cells were transfected with plasmids 
encoding GFP–lamp-1 (GFP–lgp120) and HA–hVam6p. 10 h after transfection, live cells were incubated at 37 C and scanned for GFP-
expressing cells by confocal microscopy. Live images were acquired at 30-s time intervals and are displayed as inverted images with the time 
in minutes relative to the start of imaging indicated in the lower left corner (A) or upper left corner (B and C). The dotted oval region of interest 
(C) outlines juxtanuclear regions that accumulate lysosome clusters and giant lysosomes. Arrows (A and B) point at moving vesicles. Arrow-
heads (A) point at a lysosome clustering event. n, nucleus. (D) Microtubule depolymerization impairs formation of a unified, giant juxtanu-
clear lysosomal structure in hVam6p-transfected cells. HeLa cells were transfected with Myc-hVam6p and treated with 0.5  M nocodazole 
for 16 h. Cells were then fixed-permeabilized, incubated with a rabbit polyclonal antibody to Myc and a mouse monoclonal antibody to 
lamp-1, followed by Alexa-488–conjugated donkey antibody to mouse IgG (left, green channel) and Cy3-conjugated donkey anti–rabbit IgG 
(middle, red channel). Bars, (A and C) 5  m; (B) 10  m. Quicktime movie sequence versions of this figure are available at http://www.jcb.org/
cgi/content/full/200102142/DC1. 
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ysis. Sequential immunoprecipitation with antibodies to
Myc and to HA demonstrated that the two epitope-tagged
hVam6p proteins interacted in vivo
 
 
 
(Fig. 9 B). The amount
of total HA-tagged hVam6p coprecipitated with antibody to
Myc was 10–20% in several experiments. Although this per-
centage may seem low, several combinations of epitope-
tagged proteins can be formed, namely Myc–Myc, HA–HA,
and Myc–HA. In addition, the immunoprecipitation–recap-
 
ture procedure is not quantitative because of the presence of
some SDS in the recapture step. Accordingly, the level of
Myc–HA recaptured hVam6p probably represents a signifi-
cant fraction of the total hVam6p. The coprecipitation was
specific, as Myc–hVam6p did not coprecipitate with HA-
tagged JNK1 (Fig. 9 B). These results support the observa-
tions from the sucrose gradient analyses, indicating that
hVam6p is a homooligomer.
 
Delineation of functional domains in hVam6p
 
To determine the region of hVam6p necessary for homooli-
gomerization, a series of truncations and deletions were pre-
pared (Fig. 9 A). HeLa cells were cotransfected with the
Myc- and HA-tagged hVam6p constructs, labeled with
[
 
35
 
S]methionine, and analyzed by immunoprecipitation–
recapture (Fig. 9 B). Full-length hVam6p was found to in-
teract with truncated hVam6p constructs lacking either the
CNH domain (
 
 
 
CNH) or a COOH-terminal segment
(
 
 
 
CT). However, truncation of the CLH domain in addi-
tion to the COOH-terminal segment (
 
 
 
CLH
 
 
 
CT) re-
sulted in a loss of interaction with the full-length protein.
These data point to a role for the CLH domain in self-assem-
bly of hVam6p. To assess the role of the hVam6p do-
mains in promoting lysosome clustering and fusion, we
transfected Hela cells with Myc-tagged versions of full-
length, 
 
 
 
CT, 
 
 CNH, and  CLH CT constructs (Fig. 9,
C–N). Indirect immunofluorescence microscopy for lamp-1
demonstrated that, in addition to the full-length hVam6p
(Fig. 9, C–E), the  CT protein (Fig. 9, F–H) also induced
coalescence of lysosomes (green channel, arrows in D and
G). However, loss of either the CNH domain (Fig. 9, I–K),
or the COOH-terminal segment plus CLH domain of the
protein (Fig. 9, L–N) completely abrogated the induction of
lysosome clustering and fusion (Fig. 9, I–N). Double label
immunoelectron microscopy analysis showed that both
 CNH and  CLH CT proteins lost their ability to local-
ize to lysosomes (unpublished data), suggesting that both as-
sociation with lysosomes and homo-oligomerization are req-
uisites for inducing lysosome clustering and fusion.
Discussion
Here, we report the identification and characterization of
hVam6p, a human homologue of the S. cerevisiae vacuolar
protein sorting gene product, Vam6p. We show that overex-
pression of hVam6p in human cells causes coalescence of ly-
sosomes into conglomerates of vesicles and swollen vacuoles
in the vicinity of the nucleus. Many of the vesicles in the
conglomerates have the appearance of multivesicular bodies
and some contain the CI-MPR, suggesting that they are late
endosomes. Thus, hVam6p appears to promote both homo-
typic and heterotypic clustering and fusion of lysosomes.
Heterotypic fusion seems to be restricted to late endosomes,
though, as early endosomes and other membrane-bound or-
ganelles are not affected.
Monitoring the effects of hVam6p in vivo by time-lapse
imaging of fluorescently labeled lysosomes suggests a possible
sequence of events. Peripheral lamp-containing vesicles (i.e.,
lysosomes and/or late endosomes) appear to migrate towards
the juxtanuclear cytoplasm along linear tracks. These tracks
Figure 7. hVam6p affects lysosomal morphology independently 
of Rab7 nucleotide cycling. HeLa cells were transfected with either 
GFP–Rab7 (A and B, control) or dominant-negative GFP–Rab7 
T22N (E and F, control), or were cotransfected with Myc–hVam6p 
together with either GFP–Rab7 (C and D) or GFP–Rab7 T22N (G 
and H). After 24 h, the cells were fixed-permeabilized and incu-
bated with mouse monoclonal antibodies to lamp-1. Bound anti-
bodies were revealed by Cy3-conjugated donkey anti–mouse IgG 
(B, D, F, and H), and expression of GFP–Rab7 proteins visualized by 
their intrinsic fluorescence (A, C, E, and G). Arrowheads depict the 
coalescence of both GFP–Rab7 (C) and lamp-1 (D) to a large juxta-
nuclear conglomerate. Small arrows (F) mark the localization of dis-
persed lysosomes in cells transfected with Rab7 T22N. Large arrow 
(H) denotes a giant juxtanuclear lysosome conglomerate in a cell 
overexpressing GFP–Rab7 T22N and Myc–hVam6p. Bar, 10  m.Lysosome tethering and fusion | Caplan et al. 117
likely correspond to microtubules as treatment with nocoda-
zole impairs translocation of the vesicles. Once the vesicles
arrive at the juxtanuclear area, they cluster and eventually
fuse with one another as well as with preexisting juxtanuclear
lysosomes. Over time, the clusters and/or vesicles give rise to
giant lysosomal structures reminiscent of those found in cells
from patients with Chediak-Higashi syndrome (White,
1966). Few small vesicles are seen to escape from these struc-
tures, suggesting that the vesicles are irreversibly captured
into the clusters. Electron microscopy analyses show that
many of the clusters are composed of a variable number of
regularly shaped vesicles. Some of the clusters seem to be
docked onto large vacuoles, which may precede their fusion
with or engulfment into the large vacuoles.
The phenotypic effects of hVam6p overexpression are
strongly suggestive of a role for hVam6p in tethering/dock-
ing events leading to fusion of lysosomes. Immunoelectron
microscopy analyses show that the overexpressed hVam6p
forms an electron-dense halo around vesicles containing
lamp-1 and CI-MPR in the clusters. This halo resembles an
Figure 8. Homooligomerization of hVam6p. (A) The S. cerevisiae yeast strain AH109 was cotransformed with the following GAL4ad fusion 
constructs: GAL4ad–hVam6p, GAL4ad–Rab7 Q67L, and GAL4ad–pVA3 (murine p53 control), together with the GAL4bd fusion constructs 
GAL4bd–hVam6p, GAL4bd–RILP, and GAL4bd–pTD1 (SV40 large T-antigen control). Cotransformants were assayed for growth on nonselective 
( His) and selective ( His) media. (B) Sedimentation velocity analysis of hVam6p from [
35S]methionine–labeled HeLa cells. The cell extract was 
run on a 4–20% sucrose gradient, and fractions were analyzed by sequential immunoprecipitations. The fractions were first cleared with an irrel-
evant antibody and then subjected to immunoprecipitation with a second irrelevant antibody (mouse monoclonal anti-Myc). The fractions were 
then immunoprecipitated with a mouse monoclonal antibody to the HA epitope. Fractions from the anti-Myc (control, top) and anti-HA (bottom) 
immunoprecipitations were then resolved by 4–20% gradient SDS-PAGE. Thin arrows denote markers visualized by Coomassie blue staining of 
separated fractions subjected to the same gradient conditions (albumin and catalase). The thick arrow denotes the position of AP-2, as visualized 
by immunoblotting of 10% of the labeled fractions with anti–AP-2 antibody (100/2) upon completion of the immunoprecipitations.118 The Journal of Cell Biology | Volume 154, 2001
exaggerated form of a filamentous coat that has been previ-
ously seen to connect the membranes of adjoining multive-
sicular bodies and lysosomal membranes (Futter et al.,
1996). Deposition of hVam6p onto the membranes of lyso-
somes and late endosomes likely enhances their adhesive-
ness, leading to the formation of clusters. This, in turn, in-
creases the probability of fusion resulting in the generation
of large vacuoles. Thus, overexpression of hVam6p might
simply augment the process by which lysosomes and late en-
dosomes normally exchange materials through kiss-and-run
(Storrie and Desjardins, 1996) or fusion–fission (Mullock et
al., 1998) type of interactions.
The mechanism by which hVam6p induces lysosome
clustering and fusion is still unclear. One possibility is that
hVam6p may be intrinsically capable of bridging the mem-
branes of two vesicles. Once the two vesicles are closely ap-
posed, fusion would ensue by virtue of the SNARE-based
fusion machinery. Another possibility is that overexpression
of hVam6p sequesters some other factor that normally func-
tions to prevent unregulated fusion, or to effect fission. Bio-
chemical studies of S. cerevisiae Vam6p appear to support
the first hypothesis, as this protein has been shown to be a
component of the 38S HOPS–C-Vps complex, which medi-
ates vacuole tethering/docking (Price et al., 2000a,b; Seals et
al., 2000; Wurmser et al., 2000) and trans-SNARE pairing
(Price et al., 2000b; Sato et al., 2000). HOPS–C-Vps is
thought to participate in these processes as an effector of the
Ypt–Rab GTPase, Ypt7 (Price et al., 2000a,b), and/or a gua-
Figure 9. Delineation of functional domains 
in hVam6p. (A) Schematic representation of full-
length hVam6p and various deletion constructs 
used in these experiments. (B) HeLa cells were 
cotranfected with plasmids encoding Myc– and 
HA–hVam6p, or hVam6p deletion mutants, or a 
control epitope-tagged protein (HA–JNK1), as 
indicated. After 18 h, cells were labeled for 8 h 
with [
35S]methionine, detergent extracted, and 
subjected to immunoprecipitation–recapture 
with the antibodies indicated. (C-N) HeLa cells 
were transfected with plasmids encoding Myc– 
or HA–Vam6p full-length or deletion constructs. 
After 24 h, fixed-permeabilized cells were coin-
cubated with rabbit polyclonal antibodies to ei-
ther the Myc or HA epitopes together with 
mouse monoclonal antibody to lamp-1. Bound 
antibodies were revealed by Alexa-488–conju-
gated donkey anti–mouse antibody (green chan-
nel) and Cy3-conjugated donkey anti–rabbit 
IgG (red channel). The third panel in each row 
was generated by merging of the images in the 
red and green channels. Arrows mark the coa-
lescence of lysosomes into juxtanuclear re-
gions. Bar, 10  m.Lysosome tethering and fusion | Caplan et al. 119
nine nucleotide exchange factor for Ypt7 (Wurmser et al.,
2000).
Several lines of evidence suggest that hVam6p may act
downstream or independently of Rab7: (a) overexpression of
hVam6p induces a more dramatic effect on lysosomes than
overexpression of the constitutively activated Rab7 protein
(unpublished data), (b) hVam6p induces lysosome cluster-
ing and fusion even in the presence of overexpressed domi-
nant-negative Rab7 T22N, and (c) hVam6p does not inter-
act with the constitutively activated form of Rab7. Although
by analogy with yeast Vam6p, hVam6p would be expected
to be a component of a putative human HOPS–C-Vps com-
plex, data from sucrose gradients, coimmunoprecipitations,
and two-hybrid analyses suggest that cytosolic hVam6p is a
homooligomer. In addition, we could not detect association
of hVam6p with endogenous hVam2p/Vps41p in the cyto-
sol, and overexpression of the human Vam2p/Vps41p fails
to induce effects similar to hVam6p (unpublished data).
Since yeast Vam2p/Vps41p also exists as a homooligomer in
the cytosol (Darsow et al., 2001), it is possible that Vam6p
and Vam2p may become part of the HOPS–C-Vps complex
only upon association with the vacuolar/lysosomal mem-
brane. Based on our observations, we speculate that hVam6p
may subserve the tethering/docking function of the HOPS–
C-Vps complex.
Our studies have identified two functionally important
domains within hVam6p: the CNH and CLH domains.
The CNH domain is required for association with lysosomes
and overexpression-induced lysosome clustering and fusion
(Fig. 9). This suggests that the CNH domain could interact
with a docking protein or with lipids on the lysosomal mem-
brane. Other CNH domains have been shown to mediate
interactions with the GTP-bound forms of the Rac and Rho
GTPases (Madaule et al., 1995); although, our two-hybrid
and coimmunoprecipitation analyses did not demonstrate
such binding for hVam6p (unpublished data).
The CLH domain is also required for association of
hVam6p with lysosomes and overexpression-induced lyso-
some clustering and fusion (Fig. 9). These requirements are
probably related to the ability of the CLH domain to mediate
homooligomerization of hVam6p (Fig. 9). CLH domains in
the clathrin heavy chain (Ybe et al., 1999) and S. cerevisiae
Vam2p (Darsow et al., 2001) have also been implicated in
homooligomerization, suggesting that this may be the primary
function of this domain. Thus, the effects of hVam6p on lyso-
somes appear to require homooligomerization of the protein.
In conclusion, our studies implicate hVam6p as a mamma-
lian specific tethering/docking factor that has intrinsic ability
to promote fusion of lysosomes and late endosomes in vivo.
Further studies of this protein and other mammalian homo-
logues of yeast components of the HOPS–C-Vps complex
are likely to provide a greater understanding of the mecha-
nisms involved in lysosome fusion and biogenesis. 
Materials and methods
Cloning of hVam6p
A search of DNA databases identified a human homologue of S. cerevisiae
Vam6p/Vps39p (KIAA0770, Nagase et al., 1998; for sequence data see
GenBank/EMBL/DDBJ under accession no. ABO18313.1). The complete
open reading frame of this cDNA, referred to here as hVam6p (GenBank/
EMBL/DDBJ accession number AF280814), was obtained by 5  RACE and
PCR from both Marathon-Ready
TM human brain and human heart cDNA li-
braries (CLONTECH Laboratories, Inc.), using primers designed on the ba-
sis of the partial KIAA0770 cDNA sequence. The PCR products were
cloned into the pCR2.1 vector (Invitrogen) and sequenced.
Recombinant DNA constructs
Epitope tagging at the NH2 terminus of hVam6p was performed by PCR
amplification of the full-length hVam6p using 5  primers containing the
nucleotide sequences for the HA or Myc epitopes. These products were
cloned into the EcoRV-KpnI sites of the pXS vector to yield HA–hVam6p
and Myc–hVam6p constructs, respectively. A Myc-tagged construct lack-
ing residues 1–382 (Myc– CNH) was obtained by PCR amplification using
a 5  primer containing the Myc epitope nucleotide sequence and begin-
ning with residue 383. Myc- and HA-tagged constructs encoding residues
1–560 (Myc– CT) and 1–372 (HA– CT CLH) were obtained by PCR am-
plification using the same 5  primer as done for Myc–hVam6p, but with a
3  primer encoding a stop site after residues 560 and 372, respectively. For
yeast two-hybrid assays, the GAL4ad–hVam6p and the GAL4bd–hVam6p
constructs were prepared by ligating NdeI-BamHI PCR fragments into the
multiple cloning sites of the pGADT7 (LEU2) and pGBKT7 (TRP1) vectors
(CLONTECH Laboratories, Inc.). The GAL4ad–Rab7 Q67L and GAL4bd–
RILP were provided by Dr. V. Deretic (University of Michigan Medical
School, Ann Arbor, Michigan). GFP–lgp120 (rat lamp-1) was a gift of R.
Lodge and G. Patterson (National Institutes of Health, Bethesda, MD).
Antibodies
The following monoclonal antibodies were used: HA.11 antibody to the
HA epitope and 9E10 antibody to the Myc epitope (Covance), H4A3,
H4B4, and anti-CD63 antibodies to lamp-1, lamp-2 and CD63, respec-
tively (Developmental Studies Hybridoma Bank), antibody to the CI-MPR
(Affinity Bioreagents), 7G7.B6 antibodies directed against the Tac epitope
(American Type Culture Collection), B3/25 antibody to the human transfer-
rin receptor (Roche Molecular Biochemicals), antitubulin antibodies, and
100/2 antibody to AP-2 (Sigma-Aldrich). Rabbit polyclonal antibodies to
cathepsin D (Upstate Biotechnology) or HA and Myc epitopes (Covance)
were also used.
Live imaging by time-lapse fluorescence microscopy
HeLa or COS-7 cells grown on a Lab-Tek chambered coverglass system
(Nunc) were transfected with plasmids encoding either GFP–lgp120 alone
or both GFP–lgp120 and HA–hVam6p, as described above. 10 h after
transfection, 25 mM Hepes, pH 7.4, was added to the media, and live im-
ages of the GFP-expressing cells were obtained on a ZEISS LSM 410 confo-
cal microscope. Temperature was maintained at 37 C with a Nev-Tek air-
stream stage incubator. GFP molecules were excited with the 488-nm line
of a krypton–argon laser and imaged with a 527 filter. Image acquisition,
processing, and automatic and manual data collection were performed us-
ing NIH Image v1.62 (Wayne Rasband Analytics). Live images are shown
inverted to facilitate analysis.
Electron microscopy
For HRP-uptake studies, HeLa cells were transiently transfected on cover-
slips with HA–hVam6p and incubated 24 h later with 6 mg/ml HRP (Frac-
tion VI; Sigma-Aldrich) diluted in culture medium for 4 h. Cells were fixed
with 2% glutaraldehyde in 100 mM Hepes buffer (pH 7.4). HRP enzymatic
activity was developed with 1% diaminobenzidine as previously described
(van der Sluijs et al., 1992). Cells on coverslips were treated with reduced
osmium tetroxide, dehydrated, and embedded in epoxy resin. Sections
were viewed with a Philips CM-10 transmission electron microscope. For
immunoelectron microscopy studies, HeLa cells were transiently trans-
fected, fixed with 4% formaldehyde, 0.2% glutaraldehyde in 100 mM
Hepes buffer (pH 7.4), and prepared for ultra-thin frozen sectioning as de-
scribed (Slot et al., 1991).
Other procedures
Human HeLa cells were grown on glass coverslips, transfected using FU-
GENE-6 (Roche Molecular Biochemicals), and either fixed and processed
for immunofluorescence (Dell’Angelica et al., 1997), or used directly for
analysis of rhodamine–dextran or LysoTracker
TM (Molecular Probes) up-
take, followed by fixation and processing, as described above. Microtubule
disruption was induced by treatment with 0.5  M nocodazole (Sigma-Aldrich)
for 16 h, immediately after transfection. All images were obtained using
a ZEISS LSM 410 confocal microscope. Northern blot analysis (Dell’An-
gelica et al., 1997), metabolic labeling, cell surface biotinylation (Caplan et
al., 2000), sedimentation analysis (Dell’Angelica et al., 1997), and yeast120 The Journal of Cell Biology | Volume 154, 2001
two-hybrid assays (Aguilar et al., 1997) using the strain AH109 (CLON-
TECH Laboratories, Inc.) were performed as previously described.
Online supplemental material
Online supplemental materials are available at http://www.jcb.org/cgi/
content/full/200102142/DC1. Video 1 corresponds to Fig. 6 A and con-
tains a Quicktime movie sequence depicting the centripetal movement
and fusion of GFP–lamp-1-containing vesicles in a COS-7 cell also ex-
pressing hVam6p. Images were captured every 30 s over the course of 31
min. Video 2 corresponds to Fig. 6 B and contains a Quicktime movie se-
quence demonstrating fusion of a peripheral GFP–lamp-1-containing or-
ganelle with a large juxtanuclear lysosomal structure in a HeLa cell also
expressing hVam6p. Images were captured every 30 s over the course of
200 min. Video 3 corresponds to Fig. 6 C and contains a Quicktime movie
sequence illustrating the centripetal movement and alignment of GFP–
lamp-1 structures from the periphery along the juxtanuclear axis of a COS-7
cell expressing hVam6p. Images were captured every minute over the
course of 388 min.
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